FDA Adverse Event Injury Summary report: N

PLATE, FIXATION, BONE

MDR report key: 8709092 · Received June 18, 2019

Report

Report Number
8030965-2019-65432
Event Type
Injury
Date Received
June 18, 2019
Date of Event
September 1, 2011
Report Date
May 22, 2019
Manufacturer
OBERDORF SYNTHES PRODUKTIONS GMBH
Product Code
HRS
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

BRAND NAME, COMMON DEVICE NAME, PROCODE, MFR, LOT #, PART #, UDI #, 510K: THIS REPORT IS FOR AN UNKNOWN 3.5 MM RECONSTRUCTION PLATE/UNKNOWN LOT. PART AND LOT NUMBER ARE UNKNOWN. WITHOUT THE SPECIFIC PART NUMBER; THE UDI NUMBER AND 510-K NUMBER IS UNKNOWN. DEVICE AVAILABLE FOR EVALUATION: COMPLAINANT PART IS NOT EXPECTED TO BE RETURNED FOR MANUFACTURER REVIEW/INVESTIGATION. (B)(4). DEVICE EVALUATED BY MFR, MANUFACTURE DATE: WITHOUT A LOT NUMBER THE DEVICE HISTORY RECORDS REVIEW COULD NOT BE COMPLETED. PRODUCT WAS NOT RETURNED. BASED ON THE INFORMATION AVAILABLE, IT HAS BEEN DETERMINED THAT NO CORRECTIVE AND/OR PREVENTATIVE ACTION IS PROPOSED. THIS COMPLAINT WILL BE ACCOUNTED FOR AND MONITORED VIA POST MARKET SURVEILLANCE ACTIVITIES. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. (B)(4).

Description of Event or Problem · 1

THIS REPORT IS BEING FILED AFTER THE REVIEW OF THE FOLLOWING JOURNAL ARTICLE: KAMRAN, R. ET AL (2011), PIN AND PLATE FIXATION IN COMPLEX DISTAL HUMERUS FRACTURES: SURGICAL TECHNIQUE AND RESULTS, INTERNATIONAL ORTHOPAEDICS (SICOT) (2012) VOLUME 36, PAGES 839¿844 (IRAN) DOI 10.1007/S00264-011-1343-2. THIS STUDY AIMS TO PRESENT A NOVEL TECHNIQUE OF FIXATION FOR COMPLEX DISTAL HUMERUS FRACTURES AND TO EVALUATE THE FUNCTIONAL OUTCOME OF PATIENTS WITH THIS TYPE OF FIXATION. BETWEEN MAY 2007 AND MARCH 2009, A TOTAL OF 19 PATIENTS (10 MALE 9 FEMALE)WITH AN AVERAGE AGE OF 46 YEARS (RANGE 17¿73),WITH LOW DISTAL HUMERUS FRACTURE,COMMINUTED ARTICULAR SURFACE,FRACTURE OR FRACTURES WITH POOR BONE QUALITY AND WERE PRIMARILY TREATED USING PIN AND PLATE FIXATION WERE INCLUDED IN THE STUDY. FIXATION OF THE FRACTURE WAS ATTEMPTED USING A DISTAL HUMERUS LOCKING PLATE OR 3.5-MM RECONSTRUCTION PLATE. IF THE ENTIRE OR SOME PARTS OF THE FRACTURE COULD NOT BE STABILISED BY STANDARD TECHNIQUES K-WIRES AND CONTOURED THREE- OR FOUR-HOLE RECONSTRUCTION PLATE WERE USED. THE MEAN FOLLOW-UP WAS 12 MONTHS,WITH A RANGE OF FIVE TO 22 MONTHS. THE FOLLOWING COMPLICATIONS WERE REPORTED AS FOLLOWS: A CASE OF A (B)(6) MALE HAD BRACHIAL PLEXUS INJURY AND PROXIMAL HUMERUS FRACTURE AND DID NOT ACHIEVED MAXIMAL STABILITY SCORE A CASE OF A (B)(6) FEMALE HAD SEVERE RHEUMATOID ARTHRITIS WITH MULTIPLE JOINT DEFORMITIES. A CASE OF A (B)(6) FEMALE HAD ULNAR NERVE PALSY POSTOPERATIVELY, BUT SYMPTOMS DECREASED WITH TIME AND RESOLVED IN SIX MONTHS WITH NO OBJECTIVE EVIDENCE OF DEFICIT IN THE FOLLOW-UP EVALUATION AND COLLAPSE OF CAPITULUM. A CASE OF A (B)(6) MALE HAD OLECRANON FIBROUS UNION OF THE OLECRANON WITH NO CLINICAL SYMPTOMS. A CASE OF A (B)(6) FEMALE HAD CONGENITAL RADIAL HEAD DISLOCATION UNFAVOURABLE ARC OF MOTION OF 70° 1 PATIENT HAD IMPLANT REMOVAL DUE TO COMPLAINT OF PROMINENT PIN AND SKIN IRRITATION 1 SUPERFICIAL WOUND INFECTION THAT RESOLVED WITH ORAL ANTIBIOTICS. A CASE OF A (B)(6) FEMALE DIED AFTER 5 MONTHS. THIS COMPLAINT INVOLVES TOTAL 28 DEVICES. DUE TO A LIMIT OF IMPACTED PRODUCTS PER COMPLAINT, THIS COMPLAINT WILL BE CAPTURED UNDER 4 SEPARATE COMPLAINTS AS LISTED BELOW: (B)(4). THIS REPORT IS FOR AN UNKNOWN SYNTHES 3.5 MM RECONSTRUCTION PLATE. THIS REPORT CAPTURES A CASE OF A (B)(6) FEMALE WHO HAD CONGENITAL RADIAL HEAD DISLOCATION AND UNFAVORABLE ARC OF MOTION OF 70°. THIS IS REPORT 3 OF 8 FOR (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
501020 PLATE, FIXATION, BONE HRS OBERDORF SYNTHES PRODUKTIONS GMBH

Patients

Seq Age Sex Outcome Treatment
1 24 YR Required Intervention